Skip to main content

MARSHALL WACE, LLP

Position in GPCR — Structure Therapeutics Inc.

CIK 1318757 LONDON, X0

Position in GPCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,361,662
+$11,030,705 QoQ
Shares Held
267,592
+287.2% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 190 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. GPCR ranks #54 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GPCR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,361,662 267,592
2026-03-31 $3,330,957 69,107
2025-12-31 $11,725,015 168,584
2025-06-30 $3,651,482 176,060
2025-03-31 $530,135 30,626
2024-12-31 $15,816,572 583,207
2024-09-30 $5,823,149 132,676
2024-06-30 $2,981,928 75,934
2024-03-31 $1,510,429 35,241
2023-12-31 $4,311,185 105,770
2023-09-30 $5,421,057 107,518